Archive for May, 2019

Report: Overall Cancer Mortality Continues to Decline

Report: Overall Cancer Mortality Continues to Decline

The latest Annual Report to the Nation on the Status of Cancer finds that, for all cancer sites combined, cancer death rates continued to decline in men, women and children in the United States from 1999 to 2016. Overall cancer incidence rates, or rates of new cancers, decreased in men from 2008 to 2015, after increasing from 1999 to 2008, and were stable in women from 1999 to 2015. In a special section of the report, researchers looked at cancer rates and trends in adults ages 20 to 49.

The annual report is a collaborative effort among the National Cancer Institute (NCI), part of the National Institutes of Health; the Centers for Disease Control and Prevention (CDC); the American Cancer Society (ACS); and the North American Association of Central Cancer Registries (NAACCR). The report appeared in the Journal of the National Cancer Institute on May 30, 2019.

“We are encouraged by the fact that this year’s report continues to show declining cancer mortality for men, women, and children, as well as other indicators of progress,” said Betsy A. Kohler, executive director of NAACCR. “There are also several findings that highlight the importance of continued research and cancer prevention efforts.”

The special section shows a different picture of cancer incidence and mortality among men and women ages 20 to 49 than among people of all ages. In the main report, from 2011 to 2015, the average annual incidence rate for all cancer sites combined was about 1.2 times higher among men than among women, and from 2012 to 2016, the average annual death rate among men (all ages) was 1.4 times the rate among women. However, when the researchers looked only at men and women ages 20 to 49, they found that both incidence and death rates were higher among women.

The authors reported that, in the 20–49 age group from 2011 to 2015, the average annual incidence rate for all invasive cancers was 115.3 (per 100,000 people) among men, compared with 203.3 among women, with cancer incidence rates decreasing an average of 0.7% per year among men and increasing an average of 1.3% per year among women. During the period from 2012 to 2016, the average annual cancer death rate was 22.8 (per 100,000 people) among men and 27.1 among women in this age group.

The most common cancers and their incidence rates among women ages 20 to 49 were breast (73.2 per 100,000 people), thyroid (28.4), and melanoma of the skin (14.1), with breast cancer incidence far exceeding the incidence of any other cancer. The most common cancers among men ages 20 to 49 were colon and rectum (13.1), testis (10.7), and melanoma of the skin (9.8).

“The greater cancer burden among women than men ages 20 to 49 was a striking finding of this study,” said Elizabeth Ward, Ph.D., lead author of the study and a consultant at NAACCR. “The high burden of breast cancer relative to other cancers in this age group reinforces the importance of research on prevention, early detection, and treatment of breast cancer in younger women.”

In studying this age group, the authors also found that, from 2012 to 2016, death rates decreased 2.3% per year among men and 1.7% per year among women.

“It is important to recognize that cancer mortality rates are declining in the 20-to-49-year-old age group, and that the rates of decline among women in this age group are faster than those in older women,” said Douglas R. Lowy, M.D., acting director of NCI.

The authors also reported in the special section that the incidence rates of in situ breast cancer and nonmalignant central nervous system tumors among women and men ages 20 to 49 are substantial. They wrote that some of the most frequent malignant and nonmalignant tumors that occur in this age group may be associated with considerable long-term and late effects related to the disease or its treatment. The authors conclude that access to timely and high-quality treatment and survivorship care is important to improve health outcomes and quality of life for younger adults diagnosed with cancer.

This year’s report found that, among all ages combined, existing incidence and mortality trends for most types of cancer continue. Rates of new cases and deaths from lung, bladder, and larynx cancers continue to decrease as a result of long-term declines in tobacco smoking. In contrast, rates of new cases of cancers related to excess weight and physical inactivity—including uterine, post-menopausal breast, and colorectal (only in young adults)—have been increasing in recent decades.

Several notable changes in trends were observed in the report. After decades of increasing incidence, thyroid cancer incidence rates in women stabilized from 2013 to 2015. The authors wrote that this could be due to changes in diagnostic processes related to revisions in American Thyroid Association management guidelines for small thyroid nodules.

The report also shows rapid declines in death rates for melanoma of the skin in recent years. Death rates, which had been stable in men and decreasing slightly in women, showed an 8.5% decline per year from 2014 to 2016 in men and a 6.3% decline per year from 2013 to 2016 in women.

“The declines seen in mortality for melanoma of the skin are likely the result of the introduction of new therapies, including immune checkpoint inhibitors, that have improved survival for patients diagnosed with advanced melanoma,” said J. Leonard Lichtenfeld, M.D., M.A.C.P., interim chief medical officer of ACS. “This rapid change shows us how important it is to continue working to find effective treatments for all kinds of cancer.”

Other notable findings about cancer mortality from the report include that from 2012 to 2016:

  • Overall death rates decreased 1.8% per year in men and 1.4% per year in women.
  • Among men, death rates decreased for 10 of the 19 most common cancers but increased for 6 cancers, with the steepest increases for liver cancer, oral cavity and pharynx cancer, and non-melanoma skin cancer.
  • Among women, death rates decreased for 13 of the 20 most common cancers, including the 3 most common cancers (lung and bronchus, breast, and colorectal), but increased for 5 cancer types, with the steepest increases for cancers of the uterus and liver.

For cancer incidence, from 2011 to 2015:

  • Incidence rates for all cancers combined were stable in women and decreased 2.1% per year in men.
  • Among men, rates of new cancers decreased for 8 of the 17 most common cancers, increased for 7 cancers, and were stable for 2 cancers.
  • Among women, rates of new cancers decreased for 6 of the 18 most common cancers, increased for 9 cancers, and were stable for 3 cancers.

The report also shows continuing racial and ethnic disparities in cancer mortality and incidence. When data for people of all ages were combined and compared by sex, across racial and ethnic groups, black men and black women had the highest cancer death rates, both for all cancer sites combined and for about half of the most common cancers in men and women. Black men and white women had the highest overall cancer incidence rates, and Asian/Pacific Islander men and women had the lowest overall rates. Non-Hispanic men and women had higher overall incidence rates than Hispanic men and women.

“Major declines overall in cancer mortality point in the right direction, yet significant differences remain in cancer cases and deaths based on gender, ethnicity, and race,” said CDC Director Robert R. Redfield, M.D. “A better understanding of these discrepancies improves cancer diagnosis and recovery for all patients and is vital to our public health mission.”

For more about the report, see: https://seer.cancer.gov/report_to_nation/

Posted in: Health

Leave a Comment (0) →

What Should You Consider When Planning Physician Compensation?

What Should You Consider When Planning Physician Compensation?

The changes in health care reimbursement and the rising costs of the health care business have prompted groups to look at options related to physician compensation. The addition of mid-level providers and ancillary services, the revenue and costs in a practice can look quite different than it did five to 10 years ago. A group may have adopted a compensation plan for collegiality based on keeping the group together long-term. This model is beneficial due to its simplicity, but only if the physicians worked at an equal pace and the costs were consistent among the group. It is rare to see this model, due to the fact that highly productive physicians want to be compensated for their work. Some physicians are more efficient and confident with electronic aids and can see more patients than their counterparts.

The ultimate goal in physician compensation planning is to ensure everyone believes the plan is fair, transparent and it rewards individual physicians for their work. Our team of accountants and consultants work to understand the goals of the group and the nuances that must be considered to arrive at a fair and compliant decision. The practice administrator’s opinion should be considered in compensation planning, but a trusted advisor is key to leading the effort due to the fact it is a sensitive subject that requires an objective opinion.

Six key issues are important when preparing for a change in physician compensation models. To begin, interview the physicians to get their thoughts on the current compensation structure and what should be considered in a new plan.  Secondly, review the segmentation of revenue by physicians and other billable providers. Dissect professional, technical and ancillary services and review for Stark Law implications related to physician compensation. Review employment contracts related to employed physicians or providers to assure the compliance of a proposed bonus structure.

In addition, analyze the overhead to assign costs as fixed, direct or variable categories. Fixed costs are consistent each month, such as; rent, administrative staff, equipment lease, etc. Variable costs change as the volume of service increases or decreases. Direct costs are those associated with each physician, such as individualized staff, equipment or other resources.

Fourthly, review nuances in the group related to medical directorships, mid-level supervision and lines of business, for example, Obstetrics vs. Gynecological services. Some groups are joining accountable care organizations or engaging is value-based contracts or capitated arrangements that require analysis to assure its effect on the compensation plan.

Fifthly, it is important to plan at least three options for the allocation of revenue, costs and bonus structure revealing the pros and cons for each arrangement. Place a quarter of historical data into a sample to reflect each option for every physician. This allows for questions and requested variations to arrive at the best decision for the group.

Lastly, the group and advisors should meet regularly after the new plan is implemented to address any unforeseen outcomes and continue the impact analysis of the plan.  As value-based revenue and other revenue streams evolve, it is reasonable to review the compensation plan at least every three years to assure practice changes aren’t adversely impacting the group.

Article contributed by Tammie Lunceford, Healthcare and Dental Consultant, Warren Averett Healthcare Consulting Group. Warren Averett is an official Gold Partner with the Medical Association.

Posted in: Leadership

Leave a Comment (0) →

Study: Kids Distracted By Misleading Warnings in E-Cigarette Ads

Study: Kids Distracted By Misleading Warnings in E-Cigarette Ads

E-cigarettes and vape companies are courting smokers and non-smokers alike, and they have the advertising to match. Some of the ads from one company, Blu, included “fake” advisories like “WARNING: Contains flavor.” A new study published in the journal Tobacco Control found that boys who saw ads with that type of fake warning were less likely to recall information in the ad about possible health impacts.

“The ads we found from Blu in 2017 had these fake warnings at the top that really adhered to the warning messages requirements that are now required on e-cigarette ads by the FDA,” says Brittney Keller-Hamilton, the study’s lead and a researcher at Ohio State University’s College of Public Health.

“They said things like, ‘Important: vaping Blu smells good’ and ‘Important: less harmful to your wallet,'” she says. “And we know that these messages are likely to resonate well with adolescents,” she said.

But it wasn’t just that those messages would entice the boys. Keller-Hamilton and her team found that they also distracted the readers from the actual health advisories.

“Boys who were randomly assigned to view ads with fake warnings were less likely to recall the actual warning on the advertisement or to remember health risks conveyed in that actual warning,” she said.

The FDA now requires large warnings on the ads, which Keller-Hamilton believes will make this sort of campaign harder to replicate. But it could have implications for the rest of the industry.

“This is a really big concern for cigarette ads, for instance, because those still have smaller warnings,” she said. “And cigarette ads could put fake warnings at the top of their advertisements to even further reduce the impact of their actual warnings for adolescents.”

Posted in: Health

Leave a Comment (0) →

Curry Named Local Governor of National Doctors’ Group

Curry Named Local Governor of National Doctors’ Group

BIRMINGHAM — William A. Curry, M.D., has been named governor of the Alabama Chapter of the American College of Physicians, the national organization of internists. Dr. Curry is a professor of medicine at the University of Alabama at Birmingham, and associate dean for Primary Care and Rural Health at the UAB School of Medicine.

The Board of Governors is an advisory board to the ACP Board of Regents, and implements national projects in addition to representing members at the national level. Dr. Curry’s term began during the Internal Medicine Meeting 2019, ACP’s annual scientific meeting held in Philadelphia from April 11-13.

A resident of Birmingham, Dr. Curry earned his medical degree from Vanderbilt University and became a master of ACP in 2017. Election to mastership recognizes outstanding and extraordinary career accomplishments.

Governors are elected by local ACP members and serve four-year terms. Working with a local council, they supervise ACP chapter activities, appoint members to local committees and preside at regional meetings. They also represent members by serving on the ACP Board of Governors.

Within the Alabama Chapter of ACP, Dr. Curry has served on the Chapter Council and Awards Committee, which he also chaired.

Dr. Curry is a past president of the Medical Association of the State of Alabama and has been a member of the Alabama Board of Medical Examiners and the Alabama State Committee of Public Health.

Posted in: Members

Leave a Comment (0) →

STUDY: Risk of Suicide Attempt by Children Doubles if Parent Uses Opioids

STUDY: Risk of Suicide Attempt by Children Doubles if Parent Uses Opioids

The suicide rate among young people in the U.S. has risen dramatically in the past 15 years. Over the same time period, opioid use and abuse in adults also has increased considerably. Researchers from the University of Chicago and the University of Pittsburgh reported on a connection between these two epidemics in a study published this week in JAMA Psychiatry.

“Until now, there has been little focus on the association between the increase in opioid use among adults and the risk of suicidal behavior by their children,” said Robert D. Gibbons, PhD, the Blum-Riese Professor of Biostatistics and director of the Center for Health Statistics at UChicago and senior author of the paper. “We theorized such a link was plausible because parental substance abuse is a known risk factor for suicide attempts by their children. In addition, depression and suicide attempts by parents — which are known to be related to suicidal behavior in their offspring — are more common among adults who abuse opioids.”

The researchers analyzed data from more than 240,000 parents, ages 30 to 50, between 2010 and 2016. Half of the group had filled opioid prescriptions for at least 365 days. The other half had no history of using the drug during that time. The two groups were matched on a number of factors related to suicide attempts and opioid use. Rates of suicide attempts were studied in over 330,000 children, ages 10 to 19, from these two groups of parents over the same six-year period.

Of the children whose parents used opioids, 678 (0.37%) attempted suicide. Of the sons and daughters of parents who did not use opioids, 212 (0.14%) made a suicide attempt. The researchers found that opioid use by a parent is associated with a doubling of the risk of suicide attempts by their children. The results were statistically significant even when adjusted for child age and sex, depression or substance use disorder in child or parent, and history of a suicide attempt in a parent.

“These findings demonstrate that opioid use by a parent or parents doubles the risk for suicidal behavior by their children,” said David A. Brent, MD, psychiatrist and chair of suicide studies at the University of Pittsburgh, also an author on the paper. “The epidemics of adult opiate abuse and child suicidal behavior appear to be linked, and the disturbing upward trends in mortality due to opiates and due to child suicide may have common roots.”

Gibbons and Brent call for improved diagnosis and treatment of parents who use opioids as well as mental health screening and referral to care for their children. “These actions could help reverse the upward trend in deaths due to the twin epidemics of suicide and opioid overdose,” Gibbons said.

The study, “Association Between Parental Medical Claims for Opioid Prescriptions and Risk of Suicide Attempt by Their Children,” was supported by a grant from the National Institutes of Health. Kwan Hur, PhD, in the Center for Health Statistics at the University of Chicago, was also an author of the study.

Posted in: Opioid

Leave a Comment (0) →

New Study Inspires Researchers to Hit the Road

New Study Inspires Researchers to Hit the Road

A new $21.4 million RURAL study will examine rural, southern U.S. communities to find out why people there have more disease, shorter lives. Traveling in a mobile examination van, researchers will examine 4,000 study participants over the course of six years in 10 rural counties across Kentucky, Alabama, Mississippi and Louisiana.

Vasan Ramachandran, who leads the Framingham Heart Study at Boston University, is about to embark on the ultimate road trip with 50 other scientists. But this is not for adventure and sightseeing. The research team is part of a new study led by Ramachandran, called the Risk Underlying Rural Areas Longitudinal (RURAL) study, which has the goal of discovering why people in rural areas of the southern United States tend to live shorter, less healthy lives compared to the rest of the country.

With $21.4 million in funding from the National Heart, Lung, and Blood Institute, Ramachandran and his team plan to use their know-how from the Framingham Heart Study—the longest-running heart disease study in the country—to ask the question, “What causes the high burden of heart disease, lung disease and stroke in the rural South?”

To find out the answer, the researchers will travel by custom van, built as a “mobile examination unit,” to examine 4,000 study participants over the course of six years in 10 counties across Kentucky, Alabama, Mississippi, and Louisiana. Throughout the entire US, heart disease is the number-one killer of both men and women, but rates are even worse in southern states. People living in these areas also have higher rates of lung, blood, and sleep disorders compared to the national average.

“We hope that what we do [in RURAL] changes the lives of common human beings who live in these communities, who are robust individuals like you and me,” says Ramachandran, a BU School of Medicine professor of medicine and epidemiology and chief of preventive medicine and epidemiology. “The burden of [health] risk is high, in part because of geospatial characteristics that we don’t fully understand.”

The most crucial aspect of the study, Ramachandran explains, is going to be listening. Partnering with 16 institutions, including universities in all four states, the researchers will work with participating communities to organize active discussions, working groups, listening groups, and community advisory boards. Their plan is to take the “science to the people and study these health issues at their doorstep,” Ramachandran says.

The mobile exam unit will be constructed after carefully consulting with community partners and participants, long before the examination process begins. Ramachandran says this will ensure that the space will be comfortable, accessible, and customized to the needs of specific areas. The van, once fully operational, will spend time in each county over the next few years. Counties in Alabama will be the group’s first stop to conduct baseline examinations.

“We do hope to build relationships within these communities to understand them better beyond the 4,000 people [who will participate] in RURAL,” Ramachandran says.

Six years might seem like a long time, but this is only the first step toward a much longer process and larger goal. Once the RURAL van completes its trip through all 10 counties, the cohort will continue working with the communities through advisory boards and participant networks. After the data is collected and analyzed, the team intends to share the results with district health officials and provide health recommendations based on their findings.

Posted in: Health

Leave a Comment (0) →

How Can You Help Students and Young Physicians in Debt?

How Can You Help Students and Young Physicians in Debt?

For most medical students, residents and even young physicians, debt continues to be a significant burden. According to a recent Analysis in Brief, 76% of students graduate with debt. While that percentage has decreased in the last few years, those who borrow for medical school face enormous loans: the median debt was $200,000 in 2018. At private schools, 21% of students have debt of $300,000 or more. The average four-year cost for public school students is $243,902 and $322,767 for private school students.

YOU CAN HELP! A bill was recently introduced in Congress that directly affects medical students and residents, and we need YOUR HELP to garner more support to secure its passage.

Introduced by Dr. Brian Babin (R-TX), HR 1554 (Resident Education Deferred Interest Act, or REDI Act) would allow physicians and dentists to obtain interest-free student loan deferment while training in residency. The bill is picking up steam and now has 32 co-sponsors split almost evenly between Republicans and Democrats. Simply put, this bill would be an across the board win for residents.

We encourage you to take action by asking your representatives for their support of HR 1554. A sample message is already composed for your convenience and you can reach your representatives by simply entering your contact information in the space provided.

Posted in: Advocacy

Leave a Comment (0) →

Can We Overhaul Our ‘Broken’ Health Data System?

Can We Overhaul Our ‘Broken’ Health Data System?

COLUMBUS, Ohio – Our system for protecting health data in the United States is fundamentally broken, and we need a national effort to rethink how we safeguard this information, according to three experts in data privacy.

“Data scandals are occurring on a regular basis, with no end in sight,” said Efthimios Parasidis, a co-author of the NEJM article and a professor at the Ohio State University’s Moritz College of Law and College of Public Health. “Data privacy laws for health information don’t go far enough to protect individuals. We must rethink the ethical principles underlying collection and use of health data to help frame amendments to the law.”

Parasidis wrote the article with Elizabeth Pike, Director of Privacy Policy in the Office of the Chief Information Officer at the U.S. Department of Health and Human Services; and Deven McGraw, chief regulatory office at Citizen, a company that helps people collect, organize and share their medical records digitally. Previously, McGraw was Deputy Director for Health Information Privacy at the Office of Civil Rights in the U.S. Department for Health and Human Services, and Acting Chief Privacy Officer at the Office of the National Coordinator for Health Information Technology.

Parasidis said a process analogous to the Belmont Report would be a good blueprint to follow today. The Belmont Report is one of the leading works concerning ethics and health care research. Its primary purpose is to protect subjects and participants in clinical trials or research studies. This report consists of three principles: beneficence, justice, and respect for persons.

The National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research produced the 1979 Belmont Report, which resulted in Congress passing laws to protect people who participated in medical research.

“Indignities in human subjects research compelled the government to create a commission to propose ethical guidelines for new laws. We are experiencing a rerun of what was happening then, with the scandals involving use of health data now rather than the use of human subjects,” Parasidis said. “We need an equivalent response.”

Currently, the Health Insurance Portability and Accountability Act (HIPAA) is the main law protecting the data of patients. But it doesn’t apply to many of the new companies and products that regularly store and handle customer health information, including social media platforms, health and wellness apps, smartphones, credit card companies and other devices and companies.

“All of this data held by digital health companies raises a lot of ethical concerns about how it is being used,” Parasidis said.

For example, some life insurers are offering contracts that have policyholders wear products that continuously monitor their health, and the information can be used to increase a customer’s premiums.

Most regulations require only that consumers be notified about how their information is used and give their consent.

“That system doesn’t work. Very few people read the notice and most people just click agree without knowing what they’re agreeing to,” he said.

So how can health data privacy be fixed?

One idea would be to establish data ethics review boards, which would review projects in which health data are collected, analyzed, shared or sold, according to the authors of the NEJM article.

Parasidis said such boards could function as safeguards required in both public and private settings, from university medical centers to private life insurance companies.

These boards could consider the benefits and risks of the proposed data use and consider policies governing data access, privacy and security. Members could include project developers, data analysts and ethicists, as well as people whose data would be collected.

“Right now, everything is about compliance. Companies and institutions check the boxes, fill out the forms and don’t really think about whether they’re doing the right thing,” Parasidis said.

“Deliberations about use of health data should take the ethical obligations to individuals and society into account. The law should mandate that this occurs.”

Posted in: Health

Leave a Comment (0) →

Federal Judge Rules FDA Acted Illegally in Delaying Required Review of E-Cigarettes, Cigars

Federal Judge Rules FDA Acted Illegally in Delaying Required Review of E-Cigarettes, Cigars

WASHINGTON, D.C. – In a major victory for America’s kids and public health, a federal judge has ruled that, in August 2017, the U.S. Food and Drug Administration acted illegally by allowing e-cigarettes to remain on the market until 2022 before applying for FDA authorization and by permitting products to remain on the market indefinitely during review.

In March 2018, several public health and medical organizations, and many individual pediatricians filed suit in federal court challenging this FDA decision. The lawsuit argued the FDA’s decision was unlawful, put kids at risk and harmed public health. The FDA’s delay allowed e-cigarettes – including candy, fruit, mint and menthol-flavored products that clearly appeal to kids – to stay on the market for years without a review of their public health impact. The FDA also delayed the deadline for cigar manufacturers to file such applications until 2021.

On Wednesday, U.S. District Judge Paul W. Grimm of the U.S. District Court for the District of Maryland found the FDA had exceeded its legal authority and the FDA’s delay had played a role in the skyrocketing youth use of e-cigarettes. Judge Grimm ruled the FDA’s delay gave “manufacturers responsible for the public harm a holiday from meeting the obligations of the law.”

“Instead of addressing public health concerns associated with tobacco use by minors and others, the August 2017 Guidance [which delayed the product review requirement] exacerbates the situation by stating, in essence, that manufacturers can continue to advertise and sell products that are addictive and that target a youth market … at a time when minors’ use of tobacco products like e-cigarettes is at an epidemic level and rising,” Judge Grimm wrote. “Arguably, the five-year compliance safe-harbor has allowed the manufacturers enough time to attract new, young users and get them addicted to nicotine before any of their products, labels, or flavors are pulled from the market, at which time the youth are likely to switch to one of the other thousands of tobacco products that are approved – results entirely contrary to the express purpose of the Tobacco Control Act.”

Judge Grimm gave the plaintiffs 14 days to explain what remedial action they want him to order and the FDA 14 days to respond. The FDA must take immediate action to protect our kids and require manufacturers to apply to the FDA if they want to keep their products on the market, including products like Juul that have fueled the youth e-cigarette epidemic.

Judge Grimm noted that manufacturers have had plenty of time to meet this requirement, writing that “manufacturers long have been on notice that they will have to file premarket approval applications, substantial equivalence reports, and exemption requests, and if they have chosen to delay their preparations to do so, then any hardship occasioned by their now having to comply is of their own making.”

The lawsuit was filed on March 27, 2018, by the American Academy of Pediatrics and its Maryland chapter, American Cancer Society Cancer Action Network, American Heart Association, American Lung Association, Campaign for Tobacco-Free Kids, Truth Initiative and five individual pediatricians.

Posted in: Advocacy

Leave a Comment (0) →

A Review of Alabama’s Human Life Protection Act

A Review of Alabama’s Human Life Protection Act

UPDATE MAY 24, 2019: Lawsuit filed to block abortion ban. A federal lawsuit filed Friday, May 24, asks a judge to block Alabama’s law that outlaws almost all abortions, the most far-reaching attempt by a conservative state to seek new restrictions on the procedure. The American Civil Liberties Union and Planned Parenthood filed the lawsuit on behalf of abortion providers seeking to overturn the Alabama law that would make performing an abortion at any stage of pregnancy a felony punishable by up to 99 years or life in prison for the abortion provider. The only exception would be when the woman’s health is at serious risk. The law is set to take effect in November unless blocked by a judge.

Rep. Terri Collins, the bill’s sponsor, said this: “We not only expected a challenge to Alabama’s pro-life law from ultra-liberal groups like Planned Parenthood and the ACLU, we actually invited it. Our intent from the day this bill was drafted was to use it as a vehicle to challenge the constitutional abomination known as Roe v. Wade.”


 

MAY 17, 2019: The Human Life Protection Act, or House Bill 314, was enacted into law on May 15, 2019, (the “Act”). It is important to understand that this new law is likely to be legally challenged and unlikely to go into effect anytime soon. That being said, until a court stops the enforcement, physicians should be aware of what the Act prohibits:

  • The Act makes it a Class A felony (a penalty of 10 years up to 99 years in prison) for a physician to perform an abortion, or a Class C felony (a penalty of 1 year to 10 years in prison) for a physician to attempt to perform an abortion.
  • The Act contains limited exceptions for physicians to practice medicine. It is important to note that it is the physician who may be prosecuted under the Act and not the mother of the child.

What is an abortion under the Act?

The Act is centered upon the legal definition of what is a prohibited abortion. The Act requires that in order for it to be an abortion, the woman must be known to be pregnant, and there must be an intent to terminate that pregnancy. The Act has no requirement for “viability” of the fetus for its application. The definition of abortion used in the Act provides that an abortion is the use or prescription of any instrument, medicine, drug, or other substance or device with the intent to terminate the pregnancy of a woman known to be pregnant with knowledge that the termination by those means will with reasonable likelihood cause the death of the unborn child. “Unborn child” is defined broadly by the Act as “a human being, specifically including an unborn child in utero at any stage of development, regardless of viability.” In other words, this Act protects against any abortive procedures upon any unborn child regardless of viability. If a woman is three days pregnant and knows she is pregnant, it would be a prohibited abortion for a physician to terminate that pregnancy.

What is not an abortion under the Act?

If it is not an abortion, it is not prohibited. Specifically excluded from the definition of abortion are activities done with intent to save the life or preserve the health of an unborn child, remove a dead unborn child, to deliver the unborn child prematurely to avoid a serious health risk to the unborn child’s mother, or to preserve the health of her unborn child. These activities are not an abortion, and therefore not illegal. Abortion does not include a procedure or act to terminate the pregnancy of a woman with an ectopic pregnancy, nor does it include the procedure or act to terminate the pregnancy of a woman when the unborn child has a lethal anomaly.

An ectopic pregnancy is defined as a pregnancy resulting from either a fertilized egg that has implanted or attached outside the uterus or a fertilized egg implanted inside the cornu of the uterus. A lethal anomaly is defined as a condition from which an unborn child would die after birth or shortly thereafter or be stillborn. Both pregnancies resulting from an ectopic pregnancy and pregnancies in which the unborn child has a lethal anomaly are not included in the definition of an abortion, and therefore, procedures involving either are not prohibited under the Act.

What is a serious health risk to the mother?

As provided above, an act performed by a physician in order to avoid a serious health risk to the unborn child’s mother is not an abortion and not illegal. A serious health risk to the mother may be based upon either

  1. a physical condition or
  2. an emotional or a mental illness, both of which are discussed below.

A serious health risk to the unborn child’s mother, is defined as:

In reasonable medical judgment, the child’s mother has a condition that so complicates her medical condition that it necessitates the termination of her pregnancy to avert her death or to avert serious risk of substantial physical impairment of a major bodily function. This term does not include a condition based on a claim that the woman is suffering from an emotional condition or a mental illness which will cause her to engage in conduct that intends to result in her death or the death of her unborn child. However, the condition may exist if a second physician who is licensed in Alabama as a psychiatrist, with a minimum of three years of clinical experience, examines the woman and documents that the woman has a diagnosed serious mental illness and because of it, there is reasonable medical judgment that she will engage in conduct that could result in her death or the death of her unborn child. If the mental health diagnosis and likelihood of conduct is confirmed as provided in this act, and it is determined that a termination of her pregnancy is medically necessary to avoid the conduct, the termination may be performed and shall be only performed by a physician licensed in Alabama in a hospital as defined in the Alabama Administrative Code and to which he or she has admitting privileges.

Under the Act can a physical condition of the mother be a serious health risk to the unborn child’s mother?

Yes, a physical condition may be a serious health risk to the unborn child’s mother when the mother is facing death or a serious risk of physical impairment of a major bodily function. Except in cases of a medical emergency, a physician who determines that a woman has a serious health risk must confirm his or her determination in writing by a second physician. The second physician attesting to such is immune from any civil or criminal liability. A physician has 180 days in order to obtain this determination by a second physician. Therefore, a procedure to terminate a pregnancy on a woman who has a physical condition that qualifies as a serious health risk will not be considered an abortion, and thus not prohibited by the Act.

Under the Act can a mental or emotional condition of the mother be a serious health risk to the unborn child’s mother?

Generally emotional conditions and mental illnesses may not qualify for this condition, and therefore neither will be part of an exclusion to the definition of abortion. In other words, generally a procedure to terminate the pregnancy of a woman with an emotional condition or mental health issue, with nothing else, will still be a prohibited abortion. However, if a qualified psychiatrist documents that the woman has a serious mental illness and in his or her medical judgment that she will engage in conduct that will result in her death or the death of her child, then a procedure to terminate the pregnancy may be performed in a hospital. Saying it differently, there is a limited mechanism under the Act allowing for a physician to terminate a suicidal patient’s pregnancy, or the pregnancy of a woman who will engage in conduct that will cause the death of the fetus, when a psychiatrist confirms and documents

  1. the mental health diagnosis,
  2. the likelihood of the conduct, and
  3. the medical necessity of the termination of the pregnancy.

When does this Act go into effect?

The Act shall become effective six months after it was approved by the Governor, or November 15, 2019. However, opponents have pledged to file a lawsuit to enjoin (stop) any enforcement of the Act, until the Court can make a final determination on the constitutionality of the new law.

What happens if this Act is enjoined?

The Act has a specific provision recognizing that all existing laws shall remain in effect while the new Act is being challenged in the Courts.

Posted in: Advocacy

Leave a Comment (0) →
Page 1 of 2 12